Extended Data Fig. 1: Patient cohort details with BCR::ABL1/ABL1 ratios during treatment.
From: Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia
Plots showing the clinical BCR::ABL1/ABL1 ratio (international standard levels) measured using RT-qPCR from diagnosis until last follow-up. The colours on the plot indicate an optimal (green), warning (yellow) or failure (red) of response according to European Leukemia Net recommendations, with vertical dotted lines showing the diagnosis timepoint and key post therapy timepoints (3 and 12 months) in assessing optimal response to tyrosine kinase inhibitor treatment. Black dots represent the sampling points for whole genome sequencing.
